📜 Therapeutic Goods (Legislative Instruments) Notice (No. 2) 2026
NoticeSL 2026/76 February 2026
Principal Act
This Notice identifies three therapeutic legislative instruments that have been made and published on the Federal Register of Legislation website. These instruments concern amendments to rules for authorised supply of medicines and specific instruments related to serious scarcity and substitutable medicines (Labetalol and Estradiol).
Manufacturers, suppliers, and prescribers of therapeutic goods, particularly medicines, will be affected by the new rules and instruments regarding authorised supply and management of serious scarcity medicines. This notice informs them that these federal instruments now apply as law in Western Australia.
Explore WA Government Data
Search the full archive in the free dashboard, or query programmatically via API.